STOCK TITAN

Schrödinger to Present at Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) announced that its management will participate in a fireside chat at the Jefferies Global Healthcare Conference. The event is set for June 5, 2024, at 2:30 p.m. ET. The live presentation will be available via webcast in the 'Investors' section of Schrödinger's website and will be archived for 90 days.

Positive
  • Schrödinger's participation in a high-profile event like the Jefferies Global Healthcare Conference could enhance its visibility and investor interest.
  • The company will provide a webcast of the event, increasing accessibility for interested stakeholders.
  • Archiving the presentation for 90 days allows for extended engagement and review by investors and analysts.
Negative
  • The PR does not provide any new financial or clinical data, leaving investors without updates on core business metrics.
  • There's a lack of specific business developments or strategic announcements that could positively impact stock prices in the short term.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference. The live presentation will take place on Wednesday, June 5, 2024, at 2:30 p.m. ET.

The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.

Founded in 1990, Schrödinger has approximately 850 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.

Allie Nicodemo

Schrödinger, Inc.

allie.nicodemo@schrodinger.com

617-356-2325

Source: Schrödinger

FAQ

What event will Schrödinger (SDGR) participate in?

Schrödinger will participate in a fireside chat at the Jefferies Global Healthcare Conference.

When is Schrödinger's fireside chat at the Jefferies Global Healthcare Conference?

The fireside chat will take place on June 5, 2024, at 2:30 p.m. ET.

How can I access Schrödinger's presentation at the Jefferies Global Healthcare Conference?

The live webcast can be accessed in the 'Investors' section of Schrödinger's website and will be archived for approximately 90 days.

Schrödinger, Inc.

NASDAQ:SDGR

SDGR Rankings

SDGR Latest News

SDGR Stock Data

1.50B
61.36M
2.42%
92.55%
8.62%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
NEW YORK